Background: Medication errors pose a significant risk to patients, resulting in morbidity, mortality, and unnecessary health care utilization. Pharmacists, using their professional judgment, have an important role as a final check for identifying and resolving these problems. Little is known, however, about pharmacist perspectives and experiences with dispensing or withholding potentially dangerous prescriptions. Objectives: To (a) evaluate the extent to which pharmacists would not dispense a likely harmful prescription which has been confirmed by the prescriber and (b) assess pharmacist attitudes and experiences with dispensing likely harmful prescriptions. Methods: An anonymous, self-administered, 25-item survey was emailed to members of a state pharmacy association and a pharmacy college alumni list. A series of static prescription vignettes (1 reasonable and 4 likely dangerous doses) were presented and asked if they would fill each prescriber-confirmed prescription. Pharmacists also were asked a series of Likert-type, open-ended, multiple choice, and demographic items regarding their professional experiences and role perceptions. Results: There were 497 usable responses. Three of the 4 dangerous prescriptions were withheld by the majority of pharmacists (sumatriptan as the exception). No demographic variable was universally associated with filling dangerous vignette prescriptions; rather, there were vignette-specific differences. The majority of pharmacists reported refusing to fill a potentially harmful prescription during their career. Conclusions: There appears to be meaningful variation in how pharmacists react when presented with likely harmful prescriptions. More research is needed to better understand this role, its determinants, and the potential effects on patient safety.
Introduction
In 1969, a small secret shopper experiment revealed that community pharmacists, even with the aid of prescription dispensing records, commonly missed dangerous drug interactions. 1 Medication prescribing errors remain a significant threat to patient safety despite years of interventions and research inspired by the 1999 report by the Institute of Medicine, To Err Is Human. 2, 3 This report noted that 44 000 to 98 000 people die in hospitals annually due to medication errors. Preventable prescribing errors also occur in ambulatory patients, which can result in side-effects, hospitalization, emergency room utilization, and even death. 4 While definitions of a medication error vary, the National Coordinating Council for Medication Error Reporting and Prevention defines a medication error as "any preventable event that may cause or lead to inappropriate medication use or patient harm while the medication is in the control of the health care professional, patient, or consumer." 5 Clearly preventable prescribing errors, such as an excessive initial dose of a narcotic in an opiate naive patient, are estimated to represent an important 25% of medication-related problems resulting in negative consequences such as emergency room utilization and hospitalization. [6] [7] [8] Fortunately, health care providers, such as pharmacists, and delivery processes already are in place to identify and address errors in initial prescribing before they result in patient harm.
Pharmacists are commonly recognized as the final safeguard in the medication use process to protect against medication-related problems. 9, 10 One study found 2% of new prescriptions presented in community pharmacies contained at least one error. Of these, 28% could be harmful to the patient if not addressed. 10 It is a standard expectation that a pharmacist will contact the prescriber on discovery of an inappropriate prescription (eg, improper dose or interaction) to resolve the drug therapy problem. 9, 11 Most often, this leads to a mutually acceptable resolution of the problem. Alternatively, a prescriber may be contacted, but choose not to modify the prescription, despite concern from the pharmacist. This latter scenario may produce a difficult decision for the dispensing pharmacist.
Pharmacists have a legal and ethical duty to warn patients about a dangerous dose and to refuse to fill a prescription they feel is unsafe based on professional judgment. 12 Research has investigated pharmacists refusing to fill emergency contraceptive prescriptions based on personal objections 13 ; however, little is known about the extent to which pharmacists exercise the ability to refuse to fill prescriptions based on a perceived threat to patient safety based on an identified medication-related problem.
Pharmacists differ in their perception of responsibility for patients' drug therapy outcomes, 14 which suggests there may be variation in how pharmacists approach the dispensing of potentially inappropriate medications where the prescriber has confirmed the prescription details. We report the results of a survey assessing pharmacist likelihood to dispense a series of likely dangerous prescriptions after the prescriber verified and approved the prescription. Pharmacist attitudes and experiences related to responsibility for refusing potentially inappropriate prescriptions also are presented.
Methods
A self-administered, 25-item, anonymous, cross-sectional online survey was used to assess the reaction of pharmacists to likely harmful prescription orders. The survey was sent via email to pharmacist members of 2 organizationsa Midwestern state pharmacy association and an alumni group list for a pharmacy college located in the same state. These organizations distributed the survey to their members to minimize investigators obtaining identifying information. The survey was sent to approximately 2500 pharmacists. The number of unique pharmacists contacted was appreciably lower as there was known membership overlap between organizations. The survey was conducted through the Web software, Survey Monkey and accessible for 1 month, starting on February 10, 2011. To increase response, pharmacists completing the survey could enter a drawing for one of four $50 gift cards. Reminder emails were sent 2 and 3 weeks after the survey opened. Respondents were informed that the purpose of the study was to better understand pharmacist views and actions when they are processing prescriptions. Consent for participation was assumed by completion of the survey. The study was approved by the Wheaton Franciscan Healthcare Institutional Review Board.
The first survey section contained 5 prescription vignettes (see the appendix). The first vignette (lithium) used a reasonable dose whereas the next 4 contained doses, dosing frequencies, or drug-disease contraindications likely to result in patient harm. Respondents were instructed that "you have already personally called the prescribing physician and received direct verbal confirmation that the physician wants the medication dispensed as they prescribed it." For each vignette, respondents were given the dichotomous option to fill or not fill the prescription. Each vignette was presented individually, on a single page, in a uniform order, and participants could not go back after submitting an answer. The vignette medications were selected because they commonly are used in the community setting, are listed on the Institute for Safe Medication Practices High-Alert Medication List, have an established history of causing adverse events in patients when used inappropriately, and adjustment should not be a significant factor based on differences in patient physiology or pharmacokinetics.
The first prescription, designed to serve as a control vignette, was lithium carbonate 600 mg twice daily. While lithium has a narrow therapeutic index and is dosed based on serum drug levels, this dose is well within a normal range. 15 The second prescription was for a 30-day supply of digoxin 250 µg 3 tablets daily with 1 refill. This dose is well above the normal range for a 68-year-old male. 16 The third prescription was for methotrexate 2.5 mg 3 tablets prescribed daily instead of weekly. The fourth prescription was for a fentanyl 100 µg patch for a patient with a prior 7-day history of hydrocodone/acetaminophen 7.5/500 three times daily following a total knee replacement. Fentanyl has a black box warning that fatal respiratory depression could occur in patients who are not opioid-tolerant, 17 which clearly is not the case in this vignette. The fifth prescription was for sumatriptan 50 mg for a patient who recently had a myocardial infarction. Per the manufacturer, sumatriptan should not be given to patients with a history of ischemic cardiovascular syndromes. 18 Next, pharmacists were asked a series of questions regarding their professional experiences and responsibility for medication-related problems (see the appendix).
Pharmacists were asked the frequency of dispensing potentially harmful medication orders in the past 2 weeks as well as other questions related to their decision to dispense or not dispense a potentially harmful medication. Gender, number of years in the profession, primary work environment, and work status (ie, full-time, part-time, or retired) were collected as demographic variables.
Descriptive statistics were calculated for variables. Chisquared tests were performed to identify variation in the percentage of respondents reporting they would fill the vignette prescriptions. Binary logistic regression was performed using the 4 demographic questions as independent variables and if the respondent would fill the particular vignette prescription as the dichotomous dependent variable. Poorly fitting modes, as evident by χ 2 tests, and negligible changes in predictive probability are not reported. Analyses were run using SPSS v.21.
Respondents also could provide open-ended comments or examples related to the survey. These comments were coded descriptively by 2 members of the research team (CS, MW) for the purpose of clustering responses. 19 Variation in coding was resolved using a consensus approach. Following consensus, codes were counted to provide an approximate weighting of the participant ideas. Coded segments were sorted using Microsoft Excel, summaries were generated, and representative quotes were selected.
Results
A total of 713 surveys were submitted. Responses less than 50% complete (n = 56) were excluded. To allow more interpretable comparison, responses with a primary work environment of "other" (n = 105), omission of work environment (n = 37) or with work status of retired (n = 17) or omitted (n = 1) were excluded. The remaining 497 responses were used for the analyses. Females comprised 58.1% of responses and the majority (67.8%) practiced in the community setting (Table 1) . Pharmacists early and late in their careers were most likely to respond, and most reported working full-time (87.6%). Most respondents would dispense the control, lithium prescription (93.9%). Less than 20% of respondents would fill the digoxin or methotrexate prescriptions while higher proportions would fill the fentanyl (40%) and sumatriptan (56.2%) prescriptions (Table 1) . Chi-squared tests revealed statistically significant variation in the percentage of respondents reporting they would dispense the vignette prescriptions based on the 4 pharmacist characteristics ( Table 1) .
The logistic regression modeling was useful for the fentanyl vignette ( Table 2) but not for the other vignettes. The logistic regression for the fentanyl vignette was a significant improvement, correctly predicting 65.9% of decisions, compared to 60.0% for the null model. Keeping other variables constant, males were significantly more likely than females to dispense the fentanyl prescriptions (odds ratio [OR] = 2.308); full-time pharmacists were significantly less likely to report dispensing the fentanyl prescriptions compared to part-time pharmacists (OR = 0.277). Chain pharmacists had twice the odds of dispensing the vignette fentanyl prescription compared to independent pharmacists (OR = 2.168). To illustrate the 2 most disparate predicted probabilities of the sample using the model, a male, parttime, chain pharmacist with 15 to 20 years of experience dispensing the fentanyl prescription is estimated at 85.0%, and the predicted probability of a female, full-time, independent community pharmacist with 5 to 10 years of experience is 21.6%.
In the 2 weeks prior to completing the survey, 88.7% of respondents indicated they had contacted a prescriber or prescriber representative at least once about a prescription that was seemingly incorrect because of dose, frequency, or indication with 30% of respondents indicating this occurred 6 times or more. Clarifying patient information or suggesting alternative options usually solved the issue; however, the majority (68.4%) of responders indicated they had refused to fill a prescription due to concerns of patient harm, even after verification, at some point in their career. Almost half of respondents (45.3%) reported filling a prescription where they had significant concern that it was likely to cause a bad outcome for the patient. Of these pharmacists, 75.5% said they did so because they felt the prescriber knew the medical history or clinical situation better than they did. When faced with a hypothetical prescription where the dose seemed excessive, and the pharmacist confirmed the dose, pharmacists perceived the responsibility for any adverse outcomes should primarily be apportioned to the physician (82.3%) rather than shared equally or primarily attributed to the pharmacist. Likert-type responses showed almost half (48.5%) of pharmacists disagreed that they were adequately trained in pharmacy school to deal with prescriptions for which they had significant safety concerns if they were to be filled (Table 3 ). Respondents also disagreed that concerns over patient and provider reactions would influence their decision to not fill a dangerous prescription (Table 3) .
Open-ended comments were submitted by 142 of the 497 surveys included in the overall analysis (28.6%). The most commonly applied codes, in order, were Consultation, Communicate with prescriber, Lack info, and Document ( Table 4 ). The code consultation referred to the pharmacist's practice of ensuring the patient was counseled in great 
Item Mean (SD)
It is acceptable for a pharmacist not to fill a prescription because of significant concerns for patient safety. 4.41 (0.744) If I receive direct physician approval for a prescription dosage in question and document this approval, the physician is ultimately responsible for any outcome the patient experiences from the medication.
(1.128)
A pharmacist should not fill a prescription that has a high likelihood for causing patient harm even if the physician verifies the dosage.
3.65 (0.913) I was adequately trained in my pharmacy education on how to deal with prescriptions where I had significant patient safety concerns if they were to be filled.
(1.098)
Even if I have significant concerns for patient safety, I will fill a prescription (when I have prescriber verification of the dosage) because of concern of how the PATIENT will react if I do not fill the prescription.
(0.993)
Even if I have significant concerns for patient safety, I will fill a prescription (when I have prescriber verification of the dosage) because of concern of how the PRESCRIBER will react if I do not fill the prescription. depth when being dispensed a medication where there was a concern about safety. Pharmacists stressed they would gather more information about the patient's medical condition to better understand how the medication was being used and provide extra information about potential adverse reactions anticipated with the dose in question. Several pharmacists also mentioned they would monitor the patient by checking in at a later time. Multiple pharmacists also expressed they would go beyond verifying questionable doses to ensure they understood the physicians reasoning and engage in a meaningful dialogue about the medication in question (Communicate with prescriber). In doing so, a scenario such as those presented in the survey was argued to be unlikely. However, a potential barrier to such communication was not being able to speak directly with the prescriber and instead communicating through an agent. Related to both of these codes, many pharmacists reported they would be certain to document details of their interactions with prescribers and patients, both to serve as a future information source in the care of the patient and for liability purposes. Pharmacists also reported a desire for more information, such as the condition being treated (Lack info) and a perception this would improve safety and potentially decrease the need to call and verify the dose in question. Several noteworthy concepts were voiced by seven or fewer pharmacists each. Pharmacists used information such as the prescriber's specialty (eg, psychiatrist vs general practitioner) when considering doses outside the normal range. Electronic prescribing also was an area of concern as it can be a source of additional errors. Last, excessive dosing of controlled substances appeared to be a unique phenomenon as several pharmacists reported refusing to fill prescriptions for known drug seekers or for patients of physicians the pharmacist expects are prescribing inappropriately.
Discussion
Contacting a prescriber about a potentially inappropriate dose is a common weekly, if not daily, occurrence for the pharmacists completing this survey, as well as pharmacists in other studies. 10, 11 These instances usually resolve with the prescriber and pharmacist reaching a mutually acceptable solution. The present study is the first to address a less common, but important occurrence in the career of many pharmacists-the acts of withholding and dispensing prescriptions where the pharmacist has real concerns about a prescription resulting in patient harm.
Pharmacists commonly refused the clearly inappropriate digoxin and methotrexate vignette prescriptions without the aid of computerized high-dose notice. Fentanyl, another high-dose vignette, was hypothetically dispensed by over twice as many pharmacists as the digoxin and methotrexate vignettes. This may relate to other research demonstrating variation in counseling rates depending on medication class. Those authors speculated that low rates of psychoactive medication counseling could relate to the specialized and patient-specific nature of indications and dosing associated with specific drug classes. 20 Alternatively, pharmacists could be less familiar with the dosing, interactions, and contradictions of certain medications and more familiar with others. 21, 22 These reasons also could be potential explanations of the relatively high likelihood to dispense the sumatriptan vignette prescription (ie, lack of knowledge of this particular drug-disease interaction). In addition, pharmacists may be less likely to act on drug-disease interactions compared to high doses because they are not accustomed to having such information about the patient medical history, in this case, presence of ischemic heart disease.
The different rates of dispensing the vignette prescriptions are further contextualized by other qualitative and quantitative findings. One prominent view from respondents was that since the prescriber confirmed the prescription, the prescriber must have more information which justifies the decision, and such patient-specific decisions place most responsibility for bad outcomes on the prescriber. Using the model of perceived responsibility for drug therapy outcomes, 14 one might hypothesize that pharmacists, unclear of the standards of what to do in such a scenario and feeling they do not have control since the prescriber confirmed the dose, would not feel responsible for a negative outcome. Also, according to open-ended responses, the process of discussing a dose with a physician is more nuanced than the vignettes presented in this study and respondents were confident that withholding a dangerous prescription would be rare based on the communication skills of the pharmacist. That being said, if the pharmacist cannot speak directly to the prescriber to engage in such a discussion, such dispensing scenarios may present. In addition, some pharmacists expressed their responsibility in such situations was to educate the patient about their concerns with the dose and possible complications to monitor. Prescription education and counseling is a well-established role for pharmacists from both the perspectives of the pharmacist and patient. 23 Research has shown students may not receive sufficient knowledge and training handling medication errors in a patient's medication order. 24 The legal, ethical, and practical aspects of this role as final safeguard could be a target for training both students and practicing pharmacists. Such education efforts to improve medication safety ideally would involve an interprofessional approach. 25 Future research could examine the effect of pharmacy practice act variation on pharmacist dispensing behavior. At least one state has specific practice act language that holds pharmacists immune from civil liability or criminal prosecution if they were to not fill a prescription using professional judgment. 26 Also, this study did not examine the role of technological supports in the decision making of the pharmacist.
Limitations
As with all research, this study has limitations. There was no mechanism to prevent respondents from submitting multiple surveys or to ensure the person submitting the survey was a licensed pharmacist. The vignettes were hypothetical scenarios, and the extent they parallel actual behavior has not been established. In this exploratory analysis, adjustments based on the number of statistical tests were not made. An exact response rate was not calculable and persons not completing the survey, or not submitting open-ended comments, may have unvoiced perspectives and experiences. We did not assess whether respondents consulted drug information resources as they completed the survey. Many hospital pharmacists responding to this survey do not dispense 30-day supplies of medications, so the vignettes may not have resonated as well with this group.
Conclusion
Pharmacist, patient, and prescription characteristics were associated with variation in the extent to which pharmacists reported they would dispense a series of likely dangerous vignette prescriptions. Pharmacists appeared more aligned with a patient counseling and prescriber consulting role than with withholding likely dangerous prescriptions which have been verified by the prescriber. Regardless, pharmacists have an important role as a final safeguard in the medication use process and further optimization of this role should be advocated.
Appendix

Complete Survey
A standard part of pharmacy practice is clarifying prescription orders with prescribers. For the next 5 questions you will be asked to respond, yes or no, whether you would fill and dispense a specific prescription.
Important: As you answer these questions you are to assume that YOU HAVE ALREADY PERSONALLY CALLED  THE PRESCRIBING PHYSICIAN AND RECEIVED  DIRECT VERBAL CONFIRMATION THAT THE PHY-SICIAN WANTS THE MEDICATION DISPENSED AS  THEY PRESCRIBED IT. THE PHYSICIAN SHARED THE  DIAGNOSIS WITH YOU WHEN YOU CONTACTED  THEM ABOUT THE PRESCRIPTION. ALL PATIENTS HAVE NO KNOWN DRUG ALLERGIES. . Can you recall an instance when you filled a prescription where you also had significant concern that it was likely to cause a bad outcome for the patient?
A. Yes B. No 17. If yes to the previous question, then: Why did you ultimately fill that prescription when you had significant concern? (choose one only) 
